Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for moderate to severe Alzheimer's disease
CTR20131425Phase 2Active
- Sponsor
- Shanxi Antai Biological Pharmaceutical
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in Alzheimer's disease (AD), sponsored by Shanxi Antai Biological Pharmaceutical. Started Feb 2014; status: active.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20131425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131425.